oPen Versus RobotIc retrOmuscular Repair in Medium to Large Ventral Hernias
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Basel, Switzerland
About this trial
This study investigates on the effect of two different operative techniques to treat large abdominal wall defects.
The goal of this clinical trial is to learn if the minimally-invasive, robotically-assisted ventral hernia repair (RVHR) leads to a better outcome than the open ventral hernia repair (OVHR).
The main questions it aims to answer are:
length of stay after the operation rate of complications rate of recurrence and reoperations quality of life.
Participants will:
Either be operated using the RVHR or OVHR will be followed up either in person or via email / phone call at day 7, day 30, 6 months, 1, 3 and 5 years after the surgery to asses the above-stated main and some more outcomes.
Eligibility criteria
Qualifiers
Patient age >18 years
Informed consent obtained
Transverse diameter of ventral hernia >4cm - 15cm
Eligible to open and minimally-invasive surgery according to preoperative anaesthetic assessment
Disqualifiers
precedent hernia treatment with mesh placement in the retromuscular space
precedent anterior or posterior component separation or transversus abdominis release (TAR)
active wound infection
current cancer diagnosis
Trial design
Treatments tested in this trial
- Robotically-assisted ventral hernia repair (RVHR)
- Open ventral hernia repair (OVHR)
Treatment groups
140 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
University Hospital, Basel, Switzerland
Lead sponsor
St. Clara Hospital, Basel, Switzerland
Collaborator
Klinikum Kempten, Kempten, Germany
Collaborator
Source ClinicalTrials.gov